Oral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study.

ABSTRACT:

Objective

To investigate factors associated with demographic/clinical characteristics and drug selection in patients with erectile dysfunction (ED). The prevalence of ED is increasing worldwide. Studies have shown that ED is associated with age, lifestyle and comorbidities. However, the factors associated with patient characteristics as well as drug selection are incompletely understood.

Setting

A tertiary medical centre in Kuala Lumpur, Malaysia.

Participants

A total of 219 patients (range 23-80 years) who had received phosphodiesterase type-5 (PDE-5) inhibitors as ED treatment were evaluated.

Inclusion criteria

Adult patients aged ≥18 years, diagnosed with ED, and prescribed with sildenafil, tadalafil or vardenafil.

Exclusion criteria

Patients diagnose

SUBMITTER: Zaman Huri H 

PROVIDER: S-EPMC4091539 | biostudies-literature | 2014 Jul

REPOSITORIES: biostudies-literature